APA (7th ed.) Citation

Erber, R., Angeloni, M., Stöhr, R., Lux, M. P., Ulbrich-Gebauer, D., Pelz, E., . . . Hartmann, A. (2022). Molecular subtyping of invasive breast cancer using a PAM50-based multigene expression test-comparison with molecular-like subtyping by tumor grade/immunohistochemistry and influence on oncologist’s decision on systemic therapy in a real-world setting. International journal of molecular sciences, 23(15), . https://doi.org/10.3390/ijms23158716

Chicago Style (17th ed.) Citation

Erber, Ramona, et al. "Molecular Subtyping of Invasive Breast Cancer Using a PAM50-based Multigene Expression Test-comparison with Molecular-like Subtyping by Tumor Grade/immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-world Setting." International Journal of Molecular Sciences 23, no. 15 (2022). https://doi.org/10.3390/ijms23158716.

MLA (9th ed.) Citation

Erber, Ramona, et al. "Molecular Subtyping of Invasive Breast Cancer Using a PAM50-based Multigene Expression Test-comparison with Molecular-like Subtyping by Tumor Grade/immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-world Setting." International Journal of Molecular Sciences, vol. 23, no. 15, 2022, https://doi.org/10.3390/ijms23158716.